Bleeding Disorders
Conference Coverage
In COVID-19 patients, risk of bleeding rivals risk of thromboembolism
Conference Coverage
A 4-point thrombocytopenia score was found able to rule out suspected HIT
From the Journals
Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A
Inhibitors occurred at an early age of 13 years with a prevalence of 2.6%, but were not associated with increased mortality.
Conference Coverage
Cost is the main hurdle to broad use of caplacizumab for TTP
“If we take finances out, I think almost every patient except those with a bleeding risk or bleeding problem should get it,” an investigator said...
Conference Coverage
No benefit from tranexamic acid prophylaxis in blood cancers
From the Journals
Hemochromatosis variants may confer 10-fold higher risk of liver cancer
Men of European ancestry had a greater risk of liver cancer and death if they had HFE variants.
From the Journals
Hemophilia, von Willebrand disease do not increase postop complications for ACL reconstruction
A case-control study showed outcomes were similar but hospital costs were significantly higher for patients with bleeding disorders.
From the Journals
Mouth splints decrease risk of post–dental extraction bleeding in hemophilia
From the Journals
INR fails to predict bleeding in patients with cirrhosis
The investigators hope the study findings reinforce minimizing administration of fresh frozen plasma for inappropriate correction of international...
From the Journals
Low VWF levels or blood group O not linked to intracerebral hemorrhage risk
Conference Coverage
Large cohort study: Bevacizumab safe, effective for severe HHT bleeds
Bevacizumab was effective for severe HHT-related epistaxis and GI bleeds, leading to "significant and striking improvements" on a variety of...